Summary
In the present study, we investigated the ability of epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), and insulin to protect the human breast cancer cell line MDA-231 from death induced by the antitumor drug actinomycin D (ACT-D). ACT-D is an inhibitor of RNA and protein synthesis, and its cytotoxicity may result due to continuous depletion in some vital protein molecules. Cell death was induced in the MDA-231 cells by either continuous exposure to a low dose of ACT-D (0.2µg/ml), or by a short-time exposure to a high dose of ACT-D (2µg/ml) and further culturing in the absence of the drug. Cell death was evaluated by the trypan blue dye exclusion test, the release of lactic dehydrogenase into the culture medium, and the depletion in the cellular ATP content. EGF and IGF-1, each at an optimal concentration of 20 ng/ml, enhanced substantially survival of cells exposed either to a low or a high dose of ACT-D. The combination of EGF (10 ng/ml) and IGF-1 (10 ng/ml) had an additive survival effect, which proposes that each of the growth factors enhanced survival by a distinct pathway. Insulin up to 40 ng/ml had no effect on cell survival. Pretreatment of the cells for 1 to 5 h with EGF and IGF-1 protected cells from the cytotoxic effect of ACT-D. Exposure of the cells to 2µg/ml of ACT-D for 1 h resulted in a drastic inhibition in uridine incorporation and only in a slight inhibition in leucine incorporation. Further incubation in the absence of ACT-D resulted in a continuous decrease in uridine and in leucine incorporation, either in the absence or presence of the growth factors. However, EGF and IGF-1, but not insulin, attenuated significantly this continuous decrease. We assume that EGF and IGF-1 protect cell viability by a mechanism that maintains a critical level of some vital protein molecule above the critical level at which cells die. Our finding that EGF and IGF-1 induced resistance to ACT-D suggests that growth factors may be involved in the mechanism of drug resistance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Condorelli, G.; Formisano, P.; Villone, G., et al. Insulin and insulin-like growth factor-1 (IGF-1) stimulate phosphorylation of a Mr 175,000 cytoskeleton associated protein in intact FRTLS cells. J. Biol. Chem. 264:12633–12638; 1989.
Curt, G. A.; Clendeninn, N. J.; Chabner, B. A. Drug resistance in cancer. Cancer Treat. Rep. 68:87–99; 1984.
Czech, M. P. Signal transmission by the insulin-like growth factors. Cell 59:235–238; 1989.
Frei, E. III. The clinical use of actinomycin D. Cancer Chemother. Rep. 58:49–54; 1974.
Furlanetto, R. W.; DiCarlo, J. N. Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res. 44:2122–2128; 1984.
Geier, A.; Haimsohn, M.; Beery, R., et al. Insulin-like growth factor-1 inhibits cell death induced by cycloheximide in MCF-7 cells: a model system for analyzing control of cell death. In Vitro Cell. Dev. Biol. 28A:725–729; 1992.
Geier, A.; Hemi, R.; Haimsohn, M., et al. Epidermal growth factor and insulin-like growth factor-1 preserve cell viability in the absence of protein synthesis. In Vitro Cell. Dev. Biol. 29A:231–234; 1993.
Geier, A.; Beery, R.; Haimsohn, M., et al. Serum and insulin inhibit cell death induced by cycloheximide in the human breast cancer cell line MCF-7. In Vitro Cell. Dev. Biol. 28A:415–418; 1992.
Gerschenson, L. E.; Rotello, R. J. Apoptosis: a different type of cell death. FASEB J. 6:2450–2455; 1992.
Goldfine, I. D. The insulin receptor: molecular biology and transmembrane signaling. Endocrinol. Rev. 8:235–255; 1987.
Green, D. M.; Finkelstein, J. Z.; Norkool, P., et al. Severe hepatic toxicity after treatment with single-dose dactinomycin and vincristine. Cancer (Phila) 62:270–273; 1988.
Hochhauser, D.; Harris, A. L. Drug resistance. Br. Med. Bull. 47:178–196; 1991.
Karnovsky, M. A. Formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J. Cell. Biol. 27:137–138; 1965.
Laster, S. M.; Wood, J. G.; Gooding, L. R. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J. Immunol. 141:2629–2634; 1988.
Martin, D. P.; Schmidt, R. E.; Distefano, P. S., et al. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factors deprivation. J. Cell. Biol. 106:829–844; 1988.
Martin, S. J.; Lennon, S. V.; Bonham, A. M., et al. Introduction of apoptosis (programmed all death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol. 145:1859–1867; 1990.
Moscow, J. A.; Cown, K. H. Multidrug resistance. JNCI 80:14–20; 1988.
Nieto, M. A.; Gonzales, A.; Lopez-Rivas, A., et al. IL-2 protects against anti-CD3-induced cell death in human medullary thymocytes. J. Immunol. 145:1364–1368; 1990.
Osborne, C. K.; Hamilton, B.; Titus, G., et al. Epidermal growth factor stimulation of human breast cancer cells in culture. Cancer Res. 40:2361–2366; 1980.
Perry, R. P.; Kelly, D. E. Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species. J. Cell. Physiol. 76:127–140; 1970.
Perry, R. P.; Kelly, D. E. Persistent synthesis of 5S RNA when production of 28S and 18S ribosomal RNA is inhibited by low doses of actinomycin D. J. Cell. Physiol. 72:235–246; 1968.
Pusztai, L.; Lewis, D. E.; Lorenzen, J., et al. Growth factors: regulation of normal and neoplastic growth. J. Pathol. 169:191–201; 1993.
Rozengurt, E. Early signals in the mitogenic response. Science 234:161–166; 1986.
Scher, C. D.; Young, S. A.; Locatelli, K. L. Control of cytolysis of Balb/c-3T3 cells by platelet-derived growth factors: a model system for analyzing cell death. J. Cell. Physiol. 113:211–218; 1982.
Searle, J.; Lawson, T. A.; Abbott, P. J., et al. An electron microscope study of the mode of cell death by cancer chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J. Pathol. 116:129–138; 1975.
Sellins, K. S.; Cohen, J. J. Gene induction by irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139:3199–3206; 1987.
Tamm, I.; Kikuchi, T. Insulin-like growth factor-1 (IGF-1), insulin and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent Balb/c-3T3 murine fibroblasts. J. Cell. Physiol. 143:494–500; 1990.
Tamm, I.; Kikuchi, T. Activation of signal transduction pathways protects quiescent Balb/c-3T3 fibroblasts against death due to serum deprivation. J. Cell. Physiol. 148:85–95; 1991.
Tamm, I.; Kikuchi, T.; Zychlinsky, A. Acid and basic fibroblast growth factors are survival factors with distinctive activity in quiescent Balb/c-3T3 murine fibroblasts. Proc. Natl. Acad. Sci. USA 88:3372–3376; 1991.
Williams, G. T.; Smith, C. A.; Spooncer, E., et al. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76–79; 1990.
Wyllie, A. H.; Kerr, J. F. R.; Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251–306; 1980.
Wyllie, A. H.; Morris, R. G.; Smith, A. L., et al. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142:67–77; 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Geier, A., Hemi, R., Haimsohn, M. et al. Epidermal growth factor and insulin-like growth factor-1 protect MDA-231 cells from death induced by actinomycin D: The involvement of growth factors in drug resistance. In Vitro Cell Dev Biol - Animal 30, 336–343 (1994). https://doi.org/10.1007/BF02631455
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02631455